摘要
目的探讨输入性新型冠状病毒肺炎(COVID-19)患者的流行病学特征和临床转归,为后续疫情防控和治疗提供临床参考。方法分析2020年1月21日至4月6日青岛地区62例输入性COVID-19患者的发病经过,临床特征和临床转归。结果 62例患者中,男24例,女38例,年龄5~91(52.5±15.7)岁。其中31例为家庭聚集性发病(50%),11例为医院内交叉感染(17.74%),从武汉回青岛及社区接触感染14例(22.58%),境外输入病例6例(9.68%)。由发热至确诊最长26 d。临床分型:轻型40例,普通型13例,重型7例,危重型2例。61例患者治愈出院,院内死亡1例,临床治愈率98.39%,住院时间(18.5±4.8)d。所有患者均在对症治疗基础上联合中药治疗。结论输入性COVID-19临床症状轻,以轻型病例为主,治愈率高,中药干预策略有利于病情康复,境外输入和无症状感染者是未来疫情防控重点。
Objective To explore the epidemiological characteristics and clinical outcomes of patients diagnosed with novel coronavirus(COVID-19)pneumonia(NCP),and to provide clinical reference for subsequent epidemic prevention and control.Methods The pathogenesis,clinical characteristics and clinical outcomes of 62 patients with imported novel coronavirus COVID-19 pneumonia in Qingdao area from January 21,2020 to April 6,2020 were analyzed.Results There were 24 males and 38 females,aged from 5 to 91(52.5±15.7)years.Among them,31 cases(31/62,50%)were family cluster disease,11 cases(17.74%)were nosocomial cross infection,14 cases(22.58%)came back from Wuhan to Qingdao and community contact infection,and 6 cases(9.68%)were imported from abroad.The longest time from fever to diagnosis was 26 days.Clinical classification:40 cases were mild,13 were general,7 were severe,2 were critically ill.61 cases were discharged from hospital,and 1 was dead.The clinical cure rate was 98.39%.The average stay was(18.5±4.8)days.All patients were treated combined with Chinese medicine on the basis of symptomatic treatment.Conclusions The clinical symptoms of imported NCP are relatively mild,and mild cases were more,the recovery rate was higher.The intervention strategy of traditional Chinese medicine is conducive to rehabilitation.The external input cases and symptomless infected patients are important for epidemic situation in the future.
作者
韩伟忠
林存智
高哲
吴大玮
刘宝义
Han Weizhong;Lin Cunzhi;Gao Zhe;Wu Dawei;Liu Baoyi(Department of Respiratory&Critical Care Medicine,the Affiliated Hospital of Qingdao University,Qingdao 266555,China;Department of Respiratory&Critical Care Medicine,the Qilu Hospital of Shandong University,Qingdao 266035,China)
出处
《中国医师杂志》
CAS
2021年第2期245-248,253,共5页
Journal of Chinese Physician